DK2010251T3 - System til hydrering af patient med detektion af unormal tilstand - Google Patents
System til hydrering af patient med detektion af unormal tilstand Download PDFInfo
- Publication number
- DK2010251T3 DK2010251T3 DK07755806.2T DK07755806T DK2010251T3 DK 2010251 T3 DK2010251 T3 DK 2010251T3 DK 07755806 T DK07755806 T DK 07755806T DK 2010251 T3 DK2010251 T3 DK 2010251T3
- Authority
- DK
- Denmark
- Prior art keywords
- urine
- patient
- infusion
- hydration
- weight
- Prior art date
Links
- 230000002159 abnormal effect Effects 0.000 title claims description 43
- 230000000887 hydrating effect Effects 0.000 title claims 2
- 238000001514 detection method Methods 0.000 title description 5
- 210000002700 urine Anatomy 0.000 claims description 286
- 230000036571 hydration Effects 0.000 claims description 180
- 238000006703 hydration reaction Methods 0.000 claims description 180
- 239000012530 fluid Substances 0.000 claims description 167
- 238000001802 infusion Methods 0.000 claims description 135
- 238000005259 measurement Methods 0.000 claims description 78
- 230000009471 action Effects 0.000 claims description 29
- 230000002485 urinary effect Effects 0.000 claims description 14
- 230000004044 response Effects 0.000 claims description 9
- 230000036325 urinary excretion Effects 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 description 41
- 238000000034 method Methods 0.000 description 35
- 206010029155 Nephropathy toxic Diseases 0.000 description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- 239000011780 sodium chloride Substances 0.000 description 17
- 239000002872 contrast media Substances 0.000 description 16
- 230000037452 priming Effects 0.000 description 15
- 230000008859 change Effects 0.000 description 14
- 229920005994 diacetyl cellulose Polymers 0.000 description 13
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 13
- 229960003883 furosemide Drugs 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 11
- 238000012544 monitoring process Methods 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000005303 weighing Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 238000003825 pressing Methods 0.000 description 8
- 210000003462 vein Anatomy 0.000 description 8
- 239000011800 void material Substances 0.000 description 8
- 230000018044 dehydration Effects 0.000 description 7
- 238000006297 dehydration reaction Methods 0.000 description 7
- 238000006073 displacement reaction Methods 0.000 description 7
- 239000003978 infusion fluid Substances 0.000 description 7
- 230000007257 malfunction Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 208000001647 Renal Insufficiency Diseases 0.000 description 5
- 239000002934 diuretic Substances 0.000 description 5
- 230000001882 diuretic effect Effects 0.000 description 5
- 208000028867 ischemia Diseases 0.000 description 5
- 201000006370 kidney failure Diseases 0.000 description 5
- 230000003907 kidney function Effects 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000003068 static effect Effects 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000002939 deleterious effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000002637 fluid replacement therapy Methods 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- NKAAEMMYHLFEFN-UHFFFAOYSA-M monosodium tartrate Chemical compound [Na+].OC(=O)C(O)C(O)C([O-])=O NKAAEMMYHLFEFN-UHFFFAOYSA-M 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010016803 Fluid overload Diseases 0.000 description 2
- 206010037423 Pulmonary oedema Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 239000002171 loop diuretic Substances 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000005333 pulmonary edema Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000011514 Familial renal glucosuria Diseases 0.000 description 1
- 101000734579 Homo sapiens Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100034792 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Human genes 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000011863 diuretic therapy Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005986 heart dysfunction Effects 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000005977 kidney dysfunction Effects 0.000 description 1
- 208000028485 lattice corneal dystrophy type I Diseases 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002529 medical grade silicone Polymers 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000885 nephron Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000012495 positive regulation of renal sodium excretion Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 208000007278 renal glycosuria Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/201—Assessing renal or kidney functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/207—Sensing devices adapted to collect urine
- A61B5/208—Sensing devices adapted to collect urine adapted to determine urine quantity, e.g. flow, volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01G—WEIGHING
- G01G17/00—Apparatus for or methods of weighing material of special form or property
- G01G17/04—Apparatus for or methods of weighing material of special form or property for weighing fluids, e.g. gases, pastes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3355—Controlling downstream pump pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3379—Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M2205/3393—Masses, volumes, levels of fluids in reservoirs, flow rates by weighing the reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16886—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body for measuring fluid flow rate, i.e. flowmeters
- A61M5/16895—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body for measuring fluid flow rate, i.e. flowmeters by monitoring weight change, e.g. of infusion container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/36—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests with means for eliminating or preventing injection or infusion of air into body
- A61M5/365—Air detectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physiology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
Claims (16)
1. System til hydrering af patient (10) kendetegnet ved: en indretning (20, 22) til infusion for at indgive hydrerings-fluid (26) til en patient (P); en indretning (34) til måling af en patients urinudskillelse for at måle mængden af urin (52, 53) , der er udskilt af pati enten (P); og en styreenhed (38), der reagerer på måleindretningen (36) til måling af patientens urinudskillelse og som er konfigureret til: at styre infusionsindretningen (20, 22) til at hydrere patienten (P) på basis af mængden af patientens urinudskillelse (52, 53) , at detektere en unormal måling (250) af patientens urinudskillelse og at træffe korrigerende foranstaltninger som reaktion på den unormale måling (250) af patientens urinudskillelse, kendetegnet ved, at den unormale måling er indikation på en kraftigt varierende urinudskillelse, som ikke kan være en indikation på den sande mængde urin (52, 53), der er udskilt af patienten (P) på et givet tidspunkt.
2. Systemet ifølge krav 1, i hvilket styreenheden er programmeret til: at styre infusionsindretningen til hydrering af patienten ved en forudindstillet minimal infusionshastighed, og at hydrere patienten ved en øget hastighed efter den unormale måling af en patients urinudskillelse for at opnå en forudbestemt balance af hydreringen.
3. Systemet ifølge krav 2, i hvilket indretningen til måling af en patients urinudskillelse indbefatter en indretning til måling af urinens vægt, der reagerer på en beholder af urin, som er udskilt af patienten.
4. Systemet ifølge krav 3, i hvilket nævnte unormale måling af patientens urinudskillelse indikerer en vægt af urinen i beholderen, som varierer kraftigt i et forudbestemt tidsrum.
5. Systemet ifølge krav 3, i hvilket indretningen til måling af urinens vægt indbefatter en strain-gauge, der reagerer på et vedhæng, hvorfra beholderen til urinen hænger.
6. Systemet ifølge krav 1, som yderligere indbefatter en beholder til urinudskillelsen af patienten og en unormal urinudskillelse af patienten er indikation på en urinbeholder, der er blevet mindst delvist tømt.
7. Systemet ifølge krav 6, i hvilket styreenheden er programmeret til at styre operationen af infusionsindretningen baseret på patientens urinudskillelse før og efter, at urinbeholderen blev mindst delvist tømt for at opnå en forudbestemt balance i hydreringen.
8. Systemet ifølge krav 1, i hvilket korrigerende foranstaltninger indbefatter, at styreenheden genererer et alarmsignal .
9. Systemet ifølge krav 1, der indbefatter et delsystem til måling af hydreringsfluid.
10. Systemet ifølge krav 9, i hvilket styreenheden reagerer på delsystemet til måling af hydreringsfluid og er konfigureret til: at detektere unormale målinger af hydreringsfluid, og træffe korrigerende foranstaltninger som reaktion på en unormal måling af hydreringsfluid.
11. Systemet ifølge krav 10, i hvilket delsystemet til måling af hydreringsfluid indbefatter en indretning til måling af vægt, der reagerer på en kilde for hydreringsfluid.
12. Systemet ifølge krav 11, i hvilket en unormal måling af hydreringsfluid er indikation på, at en kilde til hydreringsfluid er blevet skubbet.
13. Systemet ifølge krav 12, i hvilket de korrigerende foranstaltninger er dannelsen af et alarmsignal.
14. Systemet ifølge krav 11, i hvilket en unormal måling af hydreringsfluid er indikation på en udskiftning af kilden til hydreringsfluidet.
15. Systemet ifølge krav 14, i hvilket de korrigerende foranstaltninger er dannelsen af et alarmsignal.
16. Systemet ifølge krav 1, i hvilket infusionsindretningen er en pumpe.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/408,391 US7837667B2 (en) | 2004-09-09 | 2006-04-21 | Patient hydration system with abnormal condition sensing |
| PCT/US2007/009685 WO2007124071A2 (en) | 2004-09-09 | 2007-04-20 | Patient hydration system with abnormal condition sensing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2010251T3 true DK2010251T3 (da) | 2017-02-13 |
Family
ID=40104663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07755806.2T DK2010251T3 (da) | 2006-04-21 | 2007-04-20 | System til hydrering af patient med detektion af unormal tilstand |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2010251B1 (da) |
| DK (1) | DK2010251T3 (da) |
| ES (1) | ES2614412T3 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111110429A (zh) * | 2020-01-16 | 2020-05-08 | 南京大学 | 一种基于电容传感器的尿路造口袋中尿液监测系统与方法 |
| CN111955379B (zh) * | 2020-08-04 | 2022-10-11 | 黑龙江省农业科学院畜牧兽医分院 | 基于无线网络的羊寄生虫病监测装置及该装置的工作方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985133A (en) * | 1974-05-28 | 1976-10-12 | Imed Corporation | IV pump |
-
2007
- 2007-04-20 EP EP07755806.2A patent/EP2010251B1/en active Active
- 2007-04-20 ES ES07755806.2T patent/ES2614412T3/es active Active
- 2007-04-20 DK DK07755806.2T patent/DK2010251T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2010251A4 (en) | 2012-04-04 |
| EP2010251A2 (en) | 2009-01-07 |
| EP2010251B1 (en) | 2016-11-09 |
| ES2614412T3 (es) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7758562B2 (en) | Patient hydration system with a redundant monitoring of hydration fluid infusion | |
| US7837667B2 (en) | Patient hydration system with abnormal condition sensing | |
| US7736354B2 (en) | Patient hydration system with hydration state detection | |
| US7758563B2 (en) | Patient hydration monitoring and maintenance system and method for use with administration of a diuretic | |
| US7938817B2 (en) | Patient hydration system and method | |
| US7727222B2 (en) | Patient hydration system with taper down feature | |
| US20230414871A1 (en) | Fluid therapy method | |
| US20080027409A1 (en) | Patient hydration/fluid administration system and method | |
| DK2010251T3 (da) | System til hydrering af patient med detektion af unormal tilstand |